Table 4 Adverse events during ICU care for total sample and by gender
Adverse event | Total, n = 1,667 | Men, n = 1,195 | Women, n = 472 | P |
|---|---|---|---|---|
Bleeding | ||||
Bleeding requiring transfusion | 144 (9) | 93 (8) | 51 (11) | 0.048* |
Intracerebral bleeding | 13 (1) | 9 (1) | 4 (1) | 0.84 |
Infection | ||||
Pneumonia | 634 (38) | 483 (40) | 151 (32) | <0.001* |
Severe sepsis/septic shock | 131 (8) | 95 (8) | 36 (8) | 0.83 |
Other infection | 54 (3) | 33 (3) | 21 (4) | 0.08 |
Arrhythmia | ||||
Bradycardia (<40 beats/min) | 262 (16) | 195 (16) | 67 (14) | 0.28 |
Tachycardia (>130 beats/min) | 82 (5) | 60 (5) | 22 (5) | 0.76 |
Atrial fibrillation | 208 (13) | 155 (13) | 53 (11) | 0.33 |
Ventricular tachycardia | 179 (11) | 132 (11) | 47 (10) | 0.52 |
Ventricular fibrillation | 131 (8) | 100 (8) | 31 (7) | 0.22 |
Other arrhythmia | 73 (4) | 47 (4) | 26 (6) | 0.16 |
Metabolic or electrolyte disorder | ||||
Hypoglycemia (<3 mmol/L) | 58 (4) | 38 (3) | 20 (4) | 0.29 |
Sustained hyperglycemia (>8 mmol/L >4 hrs) | 884 (53) | 625 (52) | 259 (55) | 0.34 |
Hypokalemia (<3 mmol/L) | 433 (26) | 278 (23) | 155 (33) | <0.001* |
Hypomagnesemia (<0.7 mmol/L) | 405 (24) | 272 (23) | 133 (28) | 0.02* |
Hypophosphatemia (<0.7 mmol/L) | 331 (20) | 241 (20) | 90 (19) | 0.61 |
Clinical seizures | 443 (27) | 314 (26) | 129 (27) | 0.66 |
Body temperature exceeding 38°C during the first 7 days after cardiac arrest | 582 (36) | 441 (38) | 141 (30) | 0.01* |